Using real-world safety data in regulatory approval decisions: Sotagli…
작성자 채식영양
작성일 20-01-01 00:00
조회 0
댓글 0
본문
M. Fralick and AS. Kesselheim (2020). Using real-world safety data in regulatory approval decisions: Sotagliflozin and the risk of diabetic ketoacidosis. Pharmacoepidemiology and drug safety, 29(10), 1322-1324. https://doi.org/10.1002/pds.4994
댓글목록 0
등록된 댓글이 없습니다.
